Clark Ian T. - 12 Nov 2024 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Director
Signature
/s/ John G. Saia, as attorney-in-fact for Ian T. Clark
Issuer symbol
GH
Transactions as of
12 Nov 2024
Net transactions value
-$240,432
Form type
4
Filing time
14 Nov 2024, 17:58:32 UTC
Previous filing
10 Jul 2024
Next filing
02 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH Common Stock Options Exercise $4,498 +1,076 +6.9% $4.18 16,753 12 Nov 2024 Direct
transaction GH Common Stock Sale $31,761 -1,076 -6.4% $29.52 15,677 12 Nov 2024 Direct F1
transaction GH Common Stock Sale $213,169 -7,242 -46% $29.44 8,435 12 Nov 2024 Direct F2
transaction GH Common Stock Other $0 -8,435 -100% $0.000000 0 12 Nov 2024 Direct F3
transaction GH Common Stock Other $0 +8,435 $0.000000 8,435 12 Nov 2024 By The Thornton-Clark Family Trust, J Thornton-Clark & I Clark TTE Account F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH Stock Option (Right to Buy) Options Exercise $0 -1,076 -100% $0.000000 0 12 Nov 2024 Common Stock 1,076 $4.18 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $29.48 to $29.5357. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
F2 Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $29.43 to $29.53. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
F3 Reflects changes in form of ownership from direct to indirect due to transfer to The Thornton-Clark Family Trust, J Thornton-Clark & I Clark TTE Account.
F4 The stock option is fully vested and exercisable.